- Home
- NUWE vs PALI Comparison
NUWE vs PALI Comparison
Compare NUWE & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUWE
- PALI
- Stock Information
- Founded
- NUWE 1999
- PALI 1996
- Country
- NUWE United States
- PALI United States
- Employees
- NUWE N/A
- PALI N/A
- Industry
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NUWE Health Care
- PALI Health Care
- Exchange
- NUWE Nasdaq
- PALI Nasdaq
- Market Cap
- NUWE 3.9M
- PALI 3.2M
- IPO Year
- NUWE N/A
- PALI N/A
- Fundamental
- Price
- NUWE $0.40
- PALI $0.70
- Analyst Decision
- NUWE Strong Buy
- PALI Strong Buy
- Analyst Count
- NUWE 1
- PALI 2
- Target Price
- NUWE $17.00
- PALI $12.00
- AVG Volume (30 Days)
- NUWE 187.8K
- PALI 410.9K
- Earning Date
- NUWE 05-13-2025
- PALI 05-12-2025
- Dividend Yield
- NUWE N/A
- PALI N/A
- EPS Growth
- NUWE N/A
- PALI N/A
- EPS
- NUWE N/A
- PALI N/A
- Revenue
- NUWE $8,787,000.00
- PALI N/A
- Revenue This Year
- NUWE $26.81
- PALI N/A
- Revenue Next Year
- NUWE $48.74
- PALI N/A
- P/E Ratio
- NUWE N/A
- PALI N/A
- Revenue Growth
- NUWE N/A
- PALI N/A
- 52 Week Low
- NUWE $0.40
- PALI $0.60
- 52 Week High
- NUWE $8.40
- PALI $5.15
- Technical
- Relative Strength Index (RSI)
- NUWE 15.96
- PALI 44.12
- Support Level
- NUWE $0.76
- PALI $0.67
- Resistance Level
- NUWE $0.95
- PALI $0.86
- Average True Range (ATR)
- NUWE 0.09
- PALI 0.06
- MACD
- NUWE -0.05
- PALI -0.01
- Stochastic Oscillator
- NUWE 0.00
- PALI 22.24
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.